Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury

Journal of Neurochemistry

Volumn 97, Issue 4, 2006, Pages 1078-1088

  Christofides, J ^a   Bridel, M ^a   Egerton, M ^a   Mackay, G M ^b   Forrest, C M ^b   Stoy, N ^c   Darlington, L G ^a   Stone, T W ^b,d  

^a EPSOM GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ROYAL HOSPITAL FOR NEURO DISABILITY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

5 hydroxyindoleacetic acid (5 HIAA); 5 hydroxytryptamine (5 HT); Huntington's disease; Oxidative stress; Peroxidation; Tryptophan

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; KYNURENINE; MELATONIN; NEOPTERIN; SEROTONIN; TRYPTOPHAN;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUNTINGTON CHOREA; INFLAMMATION; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; TRAUMATIC BRAIN INJURY; TRYPTOPHAN METABOLISM;

ADMINISTRATION, ORAL; AGED; BIOLOGICAL MARKERS; BRAIN; BRAIN INJURY, CHRONIC; DOWN-REGULATION; FEMALE; FOOD, FORMULATED; HUMANS; HUNTINGTON DISEASE; HYDROXYINDOLEACETIC ACID; LIPID PEROXIDATION; MALE; MELATONIN; MIDDLE AGED; NEOPTERIN; OXIDATIVE STRESS; REFERENCE VALUES; SEROTONIN; TRYPTOPHAN; UP-REGULATION;

EID: 33646115424     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03807.x     Document Type: Article

References (50)

1. Badawy A. A. B. Morgan C. J. 1991 Effects of acute paroxetine administration on tryptophan-metabolism and disposition in the rat. Br. J. Pharmacol. 102 429 433.
2. Barrigu C. Martin M. I. Tablu R. Ortega E. Rodriguez A. B. 2001 Circadian rhythm of melatonin, corticosterone and phagocytosis: effect of stress. J. Pineal Res. 30 180 187.
3. Bates G. 2003 Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361 1642 1644.
4. Beal M. F. Matson W. R. Storey E. Milbury P. Ryan E. A. Ogawa T. Bird E. D. 1992 Kynurenic acid concentrations are reduced in huntingtons-disease cerebral-cortex. J. Neurol. Sci. 108 80 87.
5. Biggio G. Fadda F. Fanni P. Tagliamo A. Gessa G. L. 1974 Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci. 14 1321 1329.
6. Castro M. E. Pascual J. Romon T. Berciano J. Figols J. Pazos A. 1998 5-HT-1B receptor binding in degenerative movement disorders. Brain Res. 790 323 328.
7. Celada P. Artigas F. 1993 Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-a inhibition in rat-brain and peripheral-tissues. J. Neurochem. 61 2191 2198.
8. Cowen P. J. 1994 The effect of tryptophan on brain 5-HT function - a review. Human Psychopharmacol. Clin. Exp. 9 371 376.
9. Cummings T. J. Walker P. D. 1996 Serotonin depletion exacerbates changes in striatal gene expression following quinolinic acid injection. Brain Res. 743 240 248.
10. De Marchi N. Daniele F. Ragone M. A. 2001 Fluoxetine in the treatment of Huntington's disease. Psychopharmacology 153 264 266.
11. Degg T. J. Allen K. R. Barth J. H. 2000 Measurement of plasma 5-hydroxyindoleacetic acid in carcinoid disease: an alternative to 24-h urine collections? Ann. Clin. Biochem. 37 724 726.
12. Degrell I. Nagy E. 1990 Correlations between cisternal CSF and plasma-concentrations of HVA, MHPG, 5-HIAA, DA, and NA. Biol. Psychiat. 27 1179 1182.
13. Duan W. Z. Guo Z. H. Jiang H. Y. Ladenheim B. Xu X. G. Cadet J. L. Mattson M. P. 2004 Paroxetine retards disease onset and progression in huntingtin mutant mice. Ann. Neurol. 55 590 594.
14. Esteban S. Nicolaus C. Garmundi A. Rial R. V. Rodriguez A. B. Ortega E. Ibars C. B. 2004 Effect of orally administered 1-tryptophan on serotonin, melatonin and the innate immune response in the rat. Mol. Cell. Biochem. 267 39 46.
15. Fernstrom J. Wurtman R. 1971 Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173 149 151.
16. Forrest C. M. Mackay G. M. Stoy N. Darlington L. G. Stone T. W. 2005 Inflammation and the oxidative metabolism of tryptophan in the mammalian brain in Kynurenines and the Brain: from Molecules to the Clinic Vecsei L. ed.). Human Press New York in. press.
17. Fraser S. Cowen P. Franklin M. Franey C. Arendt J. 1983 Direct radioimmunoassay for melatonin in plasma. Clin. Chem. 29 396 397.
18. Grimes M. A. Cameron J. L. Fernstrom J. D. 2000 Cerebrospinal fluid concentrations of tryptophan and 5-hydroxyindoleacetic acid in Macaca mulatta: diurnal variations and response to chronic changes in dietary protein intake. Neurochem. Res. 25 413 422.
19. Guevara B. H. Torrico F. Hoffmann I. S. Cubeddu L. X. 2002 Lesion of caudate-putamen interneurons with kainic acid alters dopamine and serotonin metabolism in the olfactory tubercle of the rat. Cell. Mol. Neurobiol. 22 835 844.
20. Huether G. Hajak G. Reimer A. Poeggeler B. Blomer M. Rodenbeck A. Ruther E. 1992 The metabolic fate of infused 1-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacology 109 422 432.
21. Kubera M. Maes M. Kenis G. Kim Y. K. Lason W. 2005 Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor-alpha and Interleukin-6. Psychiat. Res. 134 251 258.
22. Kuemmerle S. Gutekunst C. A. Klein A. M. Li X. J. Li S. H. Beal M. F. Hersch S. M. Ferrante R. J. 1999 Huntingtin aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46 842 849.
23. Kuhn D. M. Arthur R. E. 1996 Inactivation of brain tryptophan hydroxylase by nitric oxide. J. Neurochem. 67 1072 1077.
24. Mackay G. M. Forrest C. M. Stoy N. Christofides J. Egerton M. Stone T. W. Darlington L. G. 2006 Tryptophan metabolism in patients with chronic brain injury. Europ. J. Neurol. 13 30 42.
25. Mattson M. P. Maudsley S. Martin B. 2004 BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 27 589 594.
26. Moja E. A. Restani P. Corsini E. Stacchezzini M. C. Assereto R. Galli C. L. 1991 Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan- free amino acid mixtures. Life Sci. 49 1121 1128.
27. Nishizawa S. Benkelfat C. Young S. N. Leyton M. Mzengeza S. de Montigny C. Blier P. Diksic M. 1997 Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl Acad. Sci. USA 94 5308 5313.
28. Pietraszek M. H. Takada Y. Yan D. Urano. T. Serizawa K. Takada A. 1992 Relationship between serotonergic measures in periphery and the brain of mouse. Life Sci. 51 75 82.
29. Pussard E. Guigieno N. Adam O. Guidicelli J.-F. 1996 Validation of HPLC amperometric detection to measure serotonin in plasma, platelets, whole blood and urine. Clin. Chem. 42 1086 1091.
30. Reiter R. J. Tan D. X. Osuna C. Gitto E. 2000 Actions of melatonin in the reduction of oxidative stress - A review. J. Biomed. Sci. 7 444 458.
31. Reynolds G. P. Pearson S. J. 1987 Decreased glutamine acid and increased 5-hydroxytryptamine in Huntington's disease brain. Neurosci. Lett. 78 233 238.
32. Reynolds G. P. Mason S. L. Meldrum A. Dekeczer S. Parnes H. Eglen R. M. Wong E. H. F. 1995 5-hydroxytryptamine (5-HT) (4) receptors in post-mortem human brain-tissue - distribution, pharmacology and effects of neurodegenerative diseases. Br. J. Pharmacol. 114 993 998.
33. Roseboom P. H. Coon S. L. Baler R. McCune S. K. Weller J. L. Klein D. C. 1996 Melatonin synthesis: analysis of the more than 150-fold nocturnal increase serotonin N-acetyltransferase messenger ribonucleic acid rat pineal gland. Endocrinology 137 3033 3044.
34. Rousseau A. Petren S. Plannthin J. Eklundh R. and Nordin C. 1999 Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers. J. Neural Transm. 106 883 888.
35. Ruiz P. J. G. Mena M. A. Bernardos V. S. Neira W. D. Roldan S. G. Benitez J. Deyebenes J. G. 1995 CSF homovanillic acid is reduced in untreated Huntington's disease. Clin. Neuropharmacol. 18 58 63.
36. Sharp T. Bramwell S. R. Grahame-Smith D. G. 1992 Effect of acute administration of 1-tryptophan on the release of 5-HT in rat hippocampus in relation to serotoninergic neuronal-activity - an in vivo microdialysis study. Life Sci. 50 1215 1223.
37. van der Stelt H. M. Broersen L. M. Olivier B. Westenberg H. G. M. 2004 Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology 172 137 144.
38. Stone T. W. MacKay G. M. Forrest C. M. Clark C. J. Darlington L. G. 2003 Tryptophan metabolites and brain disorders. Clin. Chem. Laboratory Med. 41 852 859.
39. Stoy N. Mackay G. M. Forrest C. M. Christofides J. Egerton M. Stone T. W. Darlington L. G. 2005 Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J. Neurochem. 93 611 623.
40. Strawn J. R. Ekhator N. N. Anthenelli R. M. Baker D. G. Maxwell R. A. Hill K. K. Geracioti T. D. 2002 Intra- and inter-individual relationships between central and peripheral serotonergic activity in humans: a serial cerebrospinal fluid sampling study. Life Sci. 71 1219 1225.
41. Takada A. Urano T. Yoshida M. Takada Y. 1996 Comparison of changes in serotonergic measures in whole blood or plasma and brain in rats given nicotine and/or stresses. Polish. J. Pharmacol. 48 173 177.
42. Vanhatalo S. Soinila S. 1999 Inducible expression of tryptophan hydroxylase without serotonin synthesis in hypothalamic dopaminergic neurons. Exp. Neurol. 157 305 316.
43. Waeber C. Palacios J. M. 1989 Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiography study. Neuroscience 32 337 347.
44. Williams W. A. Shoaf S. E. Hommer D. Rawlings R. Linnoila M. 1999 Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J. Neurochem. 72 1641 1647.
45. Wong E. H. F. Reynolds G. P. Bonhaus D. W. Hsu S. Eglen R. M. 1996 Characterization of [3H]GR113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders. Behav. Brain Res. 73 249 252.
46. Wu C. Singh S. K. Dias P. Kumar S. Mann D. M. 1999 Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Exp. Neurol. 158 529 533.
47. Yan D. Urano T. Pietraszek M. H. Shimoyama I. Uemura K. Kojima Y. Sakakibara K. Serizawa K. Takada Y. Takada A. 1993 Correlation between serotonergic measures in cerebrospinal-fluid and blood of subhuman primates. Life Sci. 52 745 749.
48. Yu A. Q. Yang J. X. Pawlyk A. C. Tejanibutt S. M. 1995 Acute depletion of serotonin down-regulates serotonin transporter messenger-RNA in raphe neurons. Brain Res. 688 209 212.
49. 1A receptor binding in a mouse model of Huntington's disease. J. Neurochem. 82 1416 1423.
50. Young S. N. Tourjman S. V. Teff K. L. Pihl R. O. Anderson G. H. 1988 The effect of lowering plasma tryptophan on food selection in normal males. Pharmacol. Biochem. Behav. 31 149 152.